Integra LifeSciences
(NASDAQ) IART
Integra LifeSciences Financials at a Glance
Market Cap
$731.05M
Revenue (TTM)
$1.64B
Net Income (TTM)
$516.47M
EPS (TTM)
$-6.73
P/E Ratio
-1.39
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$9.20
Volume
21,786
Open
$9.21
Price
$9.20
Volume
21,786
Open
$9.21
Previous Close
$9.20
Daily Range
$9.09 - $9.37
52-Week Range
$8.70 - $22.27
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$9.20
Volume
21,786
Open
$9.21
Previous Close
$9.20
Daily Range
$9.09 - $9.37
52-Week Range
$8.70 - $22.27
IART News
Integra Beats on the Bottom Line
IART: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Integra LifeSciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
4,427
CEO
Mojdeh Poul, MBA
Website
www.integralife.comHeadquarters
Princeton, NJ 08540, US
IART Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
4%
Net Income Margin
-32%
Return on Equity
-40%
Return on Capital
2%
Return on Assets
-14%
Earnings Yield
-71.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$731.05M
Shares Outstanding
77.94M
Volume
21.79K
Short Interest
0.00%
Avg. Volume
774.21K
Financials (TTM)
Gross Profit
$845.23M
Operating Income
$68.32M
EBITDA
$326.20M
Operating Cash Flow
$50.38M
Capital Expenditure
$81.44M
Free Cash Flow
$31.05M
Cash & ST Invst.
$263.74M
Total Debt
$2.03B
Integra LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$434.93M
-1.7%
Gross Profit
$215.36M
-13.5%
Gross Margin
49.52%
N/A
Market Cap
$731.05M
N/A
Market Cap/Employee
$166.30K
N/A
Employees
4,396
N/A
Net Income
$1.70M
-108.8%
EBITDA
$65.99M
-16.6%
Quarterly Fundamentals
Net Cash
$1.77B
-3.4%
Accounts Receivable
$278.85M
+2.4%
Inventory
$492.74M
+14.8%
Long Term Debt
$1.89B
+38.9%
Short Term Debt
$140.57M
-77.4%
Return on Assets
-14.34%
N/A
Return on Invested Capital
2.17%
N/A
Free Cash Flow
$37.25M
-433.0%
Operating Cash Flow
$11.82M
-76.7%